Article
Protection of stem cell-derived lymphocytes in a primate AIDS gene therapy model after in vivo selection.
PloS one - 2 Nov 2009
Trobridge Grant D, Wu Robert A, Beard Brian C, Chiu Sum Ying, Muñoz Nina M, von Laer Dorothee, Rossi John J, Kiem Hans-Peter
Abstract excerpt
BACKGROUND: There is currently no effective AIDS vaccine, emphasizing the importance of developing alternative therapies. Recently, a patient was successfully transplanted with allogeneic, naturally resistant CCR5-negative (CCR5Delta32) cells, setting the stage for transplantation of naturally resistant, or genetically modified stem cells as a viable therapy for AIDS. Hematopoietic stem cell (HSC) gene therapy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
